The Stanford Cancer Institute’s (SCI) mission is to reduce cancer mortality and improve cancer care through comprehensive programs of cancer research, prevention, treatment, education and outreach. To achieve its mission, the leadership and members relentlessly pursue multiple strategic aims which include fostering interdisciplinary basic cancer research, translating scientific discovery into clinical research and optimal patient care, developing improved approaches to the prevention, early detection, precise diagnosis and effective treatment of cancer, and improving the cancer patient experience by using research to develop and validate innovative initiatives in patient-centered care.
In keeping with its core mission, the SCI offers Innovation Awards to support projects focused on the acceleration of basic, translational, clinical and population-based cancer research, and projects focused on specific types of cancer, such as pancreatic, breast and gynecologic cancers. This award cycle, we encourage proposals related to the Priority Cancers-Breast, Pancreatic, Liver, Lung, and Lymphoma.
- Stanford Cancer Institute Nodal Grant Awards ($50,000)
- Stanford Cancer Institute Innovation Awards ($50,000)
- Single PI
- Multi PI collaboration leading to multi PI peer-reviewed funding
- Stanford Cancer Institute Pancreatic Cancer Innovation Awards ($50,000)
- Stanford Women's Cancer Center Innovation Awards ($50,000)
- Shmunis Family Innovation Awards in Cancer Therapeutics ($50,000)
AWARD CATEGORY DESCRIPTIONS:
Stanford Cancer Institute Nodal Grant Awards (SCI-NGA) - $50,000
The SCI offers a funding mechanism, which aims to catalyze the planning and execution of multi-PI grants from the National Cancer Institute, including R01s, P01s and SPOREs. The funds are intended to be used to obtain proof of concept data and support planning activities.
Stanford Cancer Institute Cancer Innovation Award (SCI-IA) - $50,000
The SCI offers awards to support projects focused on the acceleration of basic, translational, clinical and population-based cancer research and collaborations leading to multi PI peer-reviewed funding.
Stanford Cancer Institute Pancreatic Cancer Innovation Award (SCI-PCIA) - $50,000
The SCI offers awards leading to a greater understanding of pancreatic cancer, with the ultimate goal of improving the prevention or treatment of pancreatic cancer.
Stanford Women’s Cancer Center Innovation Award (SWCC-IA) - $50,000
With support from the fundraising efforts of Under One Umbrella, the SCI and the Stanford Women’s Cancer Center offer awards for research projects related to women’s cancers.
Shmunis Family Innovation Awards in Cancer Therapeutics (SCI-CT)- $50,000
The SCI is pleased to offer these new awards focused on cancer drug development and cancer therapeutics. We encourage proposals that are “high-risk, high-reward drug development projects” which enable researchers to develop and therapeutic modalities that could lead to early phase clinical trials and transformative new treatments for patients.
TIMELINE (Anticipated / Exact dates TBD)
RFA Announced: April 15, 2022
Proposal submission deadline: June 10, 2022
Notification of Selection: August 1, 2022
Funding Period: October 1, 2022 – September 30, 2023
- Bold and creative research projects
- Research related to health disparities
- Multi-disciplinary collaboration, including collaborations involving Stanford faculty beyond the School of Medicine or inter-programmatic collaborations across the seven SCI research programs
- Potential to lead (or is already leading) to an investigator-initiated clinical trial
- Plans for submission of an external peer reviewed (preferably NCI) application
Faculty members of the SCI or of the Stanford University community with PI Status.
Instructors may not serve as PI, but must be partnered with an SCI member with PI status.
***If the PI is not a SCI member, the submission must include a letter of support from a sponsoring SCI member, who would also be a project collaborator.
Please note, University Research Agreements (URAs) now require COI (OPACS) for all Co-PIs. As a Co-PI on this project, your Conflicts of Interest (COI) needs to be done before this award amendment can be released in SERA. Please be sure to go into OPACS https://opacs.stanford.edu/ to complete your COI declarations for the noted project if you haven't done so.
IMPORTANT: If you are interested in submitting more than 1 project, please contact Gayle White at firstname.lastname@example.org prior to proposal submission of either proposal. Seedfunding.stanford.edu will only allow 1 proposal per PI (sunet ID), per funding opportunity.
Progress reports will be required at 12 and 24 months after funding begins. Earlier progress reports will be requested if the award recipient is leaving the University. Recipients may be asked to present the results of funded research project at the request of the SCI.
In accordance with University research guidelines, funds may be used for:
- PI Salary Support (minimum of 1% of the NIH salary cap ($203,702) not to exceed 10% of total award)
- Other personnel directly supporting the proposed project
- Equipment and supplies
- SCI will allow up to 5K for capital equipment
- Once awarded, compliance documents (IRB or APLAC) will need to be obtained to process the PDRF in the Stanford Electronic Research Administration (SERA) system
- Only DIRECTS should be shown in the budget